# A University of Pretoria expert calls for cautious optimism following the launch of the South African-led HIV vaccine trial, Brilliant 011, in Cape Town. The university’s Theresa Rossouw says the study marks an important scientific step in the long and complex search for an HIV vaccine but it’s not a breakthrough or cure. Rossouw added HIV remains difficult to target, although continued advances in treatment and prevention offer hope. She also emphasised that clear communication and public trust are essential as the research progresses.
University of Pretoria expert cautiously optimistic over HIV vaccine trial